SARS-CoV-2 (COVID-19) NSP7 Antibody

Primary Antibodies

SARS-CoV-2 (COVID-19) NSP7 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3, 4, 5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

Trial Size, New

SARS-CoV-2 (COVID-19) NSP7 Antibody is affinity chromatography purified via peptide column.

SARS-CoV-2 (COVID-19) NSP7 Antibody is supplied in PBS containing 0.02% sodium azide.

Predicted reactivity based on immunogen sequence: SARS-CoV NSP7 protein: (100%)

Polyclonal

Severe acute respiratory syndrome coronavirus 2

Optimal dilutions for each application to be determined by the researcher.